MLMicah E. Lubensky

Micah E. Lubensky

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Micah E. Lubensky has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Age‐Related Trends in Eating‐Pathology Symptoms Among Sexual Minority Adults

    by Jason M. Nagata, Christopher D. Otmar, Char Potes, Ken Murakami, Jason M. Lavender, Emilio J. Compte, Tiffany A. Brown, Kelsie T. Forbush, Annesa Flentje, Micah E. Lubensky, et al.

    Objective: To examine how eating‐disorder symptoms vary by chronological age and sexual orientation in sexual minority adults. Method: Cross‐sectional data came from 2062 cisgender sexual minority participants (925 gay men, 573 lesbian women, 116 bi+ men, 448 bi+ women; age = 47.8 years, range = 18–96). Eight subscales from the Eating Pathology Symptoms Inventory were examined. A multivariate multivariable general linear model tested main and interaction effects of age and sexual orientation; significant multivariate multivariable findings were probed with false‐discovery‐rate‐adjusted univariate regressions. Results: Older age was associated with lower body dissatisfaction, binge eating, and muscle‐building behaviours, but higher cognitive restraint and negative attitudes toward obesity. Age‐by‐group interactions indicated that body dissatisfaction and binge eating were higher among older cisgender bi+ women, whereas muscularity‐oriented behaviours were lower in lesbian and bi+ women compared to gay men. Associations remained after socioeconomic covariate adjustment. Conclusions: Findings suggested that levels of eating pathology varied based on age and across sexual minority groups. Bi+ women showed increasing body dissatisfaction and binge eating with age, while lesbian and bi+ women reported lower muscularity‐oriented behaviours relative to gay men. Life‐course prevention and treatment strategies should address identity‐specific stress ecologies and the needs of adult sexual minority populations.

  • Breastfeeding and Chestfeeding Experiences of Cisgender Sexual Minority Women, Transgender, and Gender Diverse Parents

    by Diana M. Tordoff, Mitchell R. Lunn, Danit Ariel, Susan Crowe, Micah E. Lubensky, Annesa Flentje, Juno Obedin-Maliver

    Background: Sexual and gender minority adults are increasingly growing their families and having children, yet there is limited information on the lactation experiences of sexual and gender minority parents. Method: Using data from The PRIDE Study, a national cohort of sexual and gender minority adults in the United States, we examined patterns and correlates of lifetime breast/chestfeeding among sexual minority (i.e., lesbian, bisexual, queer) cisgender women, transgender women, transgender men, and gender diverse individuals who were parents. Results: Our analysis included 1,562 parents aged 19–83 years with a median of two children (IQR 1–3). Among this population, 941 (60.2%) were sexual minority cisgender women, 232 (14.9%) transgender women, 199 (12.7%) transgender men, and 190 (12.2%) gender diverse parents assigned female at birth. Among 962 parents who had ever carried a pregnancy and delivered a child, sexual minority cisgender women were most likely to have ever breast/chestfed (91.7%), followed by gender diverse parents (88.8%) and transgender men (83.3%). No other demographic factors were associated with ever breast/chestfeeding. Few participants (6.7%) had ever breast/chestfed a child from another person’s pregnancy. Ever having delivered a child and having an increasing number of children were associated with ever breast/chestfeeding a child from another person’s pregnancy. In addition, seven (3%) transgender women had ever breast/chestfed a child. Conclusions: In our cohort, rates of lifetime breast/chestfeeding were high among sexual and gender minority parents who had ever carried a pregnancy. Breast/chestfeeding provides important health and infant–parent bonding benefits in families where one or more parents has the interest in and capacity for lactation. Co-lactation and/or lactation induction may be particularly beneficial for sexual and gender minority families.

  • Side Effect Profiles of Nonhormonal, Nonsurgical Gender-Affirming Body Modifications

    by Ben L. Schwartz, Nguyen K. Tran, Jonathan A. Mayo, Sarah M. Peitzmeier, Tonia C. Poteat, Micah E. Lubensky, Annesa Flentje, Juno Obedin-Maliver, Mitchell R. Lunn

    Purpose: Binding, packing, using stand-to-pee (STP) devices, and tucking are nonhormonal, nonsurgical gender-affirming body modifications (GABMs) that are used to affirm gender expression. This study sought to describe the sociodemographic characteristics of and side effects experienced by those using GABMs. Methods: We conducted a cross-sectional study of The Population Research in Identity and Disparities for Equality Study participants who completed the 2023 Annual Questionnaire. Data on sociodemographics and self-reported side effects were collected and analyzed using descriptive statistics. Results: Of 6296 participants, 1694 reported GABMs including binding ( n = 995), packing ( n = 590), using an STP device ( n = 351), and tucking ( n = 265). Each GABM had a distinct side effect profile. Pain (2.0%–48.2% past-year prevalence) and dermatologic concerns (0.5%–23.2% past-year prevalence) were reported across GABMs. Conclusion: While GABMs promote mental health and patient safety, they carry a risk of adverse physical health effects. Providers play a vital role in managing GABM-associated side effects to ensure patients can continue to affirm their gender identities.

  • Open Access

    Age-related trends in eating pathology symptoms among transgender and gender-diverse adults

    by Jason M. Nagata, Christopher D. Otmar, Christopher M. Lee, Emilio J. Compte, Jason M. Lavender, Tiffany A. Brown, Kelsie T. Forbush, Annesa Flentje, Micah E. Lubensky, Juno Obedin-Maliver, et al.

    Purpose: This study examined how eating disorder symptoms, assessed by the Eating Pathology Symptoms Inventory (EPSI), vary across chronological age in a large national (USA) sample of transgender and gender-diverse (TGD) adults. Method: Participants were 2098 TGD adults—including transgender men (n = 599), transgender women (n = 293), and gender-diverse individuals (n = 1,206, including nonbinary and those who identified with “another gender identity”)—enrolled in The PRIDE Study. A multivariate general linear model tested the effects of chronological age, gender group (with gender-diverse as the reference), and their interaction on the eight EPSI scales. Results: Multivariate analyses showed significant main effects of age (V = .045, p < .001) and gender group (V = .098, p < .001), but no significant age-by-group interaction. Older age was associated with greater Cognitive Restraint (β = .22, p < .001), Negative Attitudes toward Obesity (β = .22, p < .001), and Excessive Exercise (β = .12, p = .001). Compared to gender-diverse individuals, transgender men exhibited higher Muscle Building, Cognitive Restraint, and Excessive Exercise scores, whereas transgender women reported higher Binge Eating, Purging, Cognitive Restraint, and Negative Attitudes toward Obesity, but lower Muscle Building. A single significant interaction indicated that transgender women showed stronger age-related differences in Purging. Conclusions: These findings contribute to growing evidence that disordered eating symptoms may not simply resolve with age among TGD individuals and necessitate lifespan-sensitive approaches to eating disorder care. These patterns likely capture a mix of aging processes and cohort-specific exposures to weight-normative and cis-normative ideals. Level of evidence Level V: based on descriptive studies.


  • The hidden human cost of defunded LGBTQIA+ health research

    by David J. Kinitz, Micah E. Lubensky, Nguyen K. Tran, Annesa Flentje, Mitchell R. Lunn


  • Open Access

    Community norms of the Eating Pathology Symptoms Inventory (EPSI) in transgender and gender-diverse adults

    by Jason M. Nagata, Christopher D. Otmar, Christopher M. Lee, Emilio J. Compte, Jason M. Lavender, Tiffany A. Brown, Kelsie T. Forbush, Annesa Flentje, Micah E. Lubensky, Mitchell R. Lunn, et al.


  • Open Access

    Factor Structure, Internal Consistency, and Measurement Invariance of the Eating Pathology Symptoms Inventory (EPSI) in Transgender and Gender‐Diverse Adults

    by Jason M. Nagata, Christopher D. Otmar, Audrey Lopez, Emilio J. Compte, Jason M. Lavender, Tiffany A. Brown, Kelsie T. Forbush, Annesa Flentje, Micah E. Lubensky, Juno Obedin‐Maliver, et al.

    Objective: This study aimed to examine the psychometric properties, including factor structure, internal consistency, and measurement invariance of the Eating Pathology Symptoms Inventory (EPSI) in a large national sample of transgender and gender‐diverse (TGD) adults.Method: The sample consisted of 2098 TGD adults—including transgender men (n = 599), transgender women (n = 293), and gender‐diverse individuals (n = 1206)—who completed online self‐report surveys. Using a subset of the sample, exploratory factor analysis (EFA) was conducted to identify underlying factor structures, followed by confirmatory factor analysis (CFA) to confirm the model fit within each population in the remainder of the sample. Multi‐group confirmatory factor analysis (MG‐CFA) was used to assess measurement invariance across transgender men, transgender women, and gender‐diverse individuals.Results: The EPSI's eight‐factor structure was supported across all three TGD groups with strong model fit: transgender men (CFI = 0.985, RMSEA = 0.047, SRMR = 0.078), transgender women (CFI = 0.948, RMSEA = 0.048, SRMR = 0.085), and gender‐diverse individuals (CFI = 0.962, RMSEA = 0.040, SRMR = 0.060). Measurement invariance analyses supported that the EPSI was invariant across the groups, facilitating meaningful group comparisons using the inventory. Internal consistency, assessed using McDonald's omega, was acceptable for all subscales (ω = 0.74–0.94).Discussion: This study provides psychometric support for the EPSI in TGD groups. The results indicate that the EPSI performs reliably and consistently across these groups for assessing eating pathology among gender minority people.


  • Open Access

    Community norms of the Eating Pathology Symptoms Inventory (EPSI) in cisgender sexual minority adults

    by Jason M. Nagata, Christopher D. Otmar, Christopher M. Lee, Emilio J. Compte, Jason M. Lavender, Tiffany A. Brown, Kelsie T. Forbush, Annesa Flentje, Micah E. Lubensky, Juno Obedin-Maliver, et al.

    Purpose: Cisgender sexual minority adults are at elevated risk for eating disorders; however, community norms for certain eating disorder measures are lacking for this population. This study aimed to establish community norms for the Eating Pathology Symptom Inventory (EPSI) among cisgender gay, lesbian, bisexual + (individuals who identify as bisexual or pansexual; bi +) adults. Methods: Cross-sectional data were analyzed from 2062 cisgender participants—including 925 gay men, 573 lesbian women, 116 bi + men, and 448 bi + women—enrolled in The PRIDE Study, a national longitudinal cohort of sexual and gender minority adults in the United States. Participants completed the EPSI, and descriptive statistics were calculated for the eight EPSI scales. Results: We report mean scores, standard deviations, medians, interquartile ranges, and percentile ranks for the eight EPSI scales within cisgender sexual minority populations. Distinct patterns of eating-pathology symptoms were evidenced among the cisgender sexual minority groups. Cisgender bi + women exhibited the highest scores for Body Dissatisfaction, Binge Eating, and Restricting compared to other groups, whereas cisgender bi + men reported the highest scores for Excessive Exercise. Cisgender gay men had significantly higher scores for Muscle Building and Negative Attitudes Toward Obesity compared to other groups. Conclusion: These findings offer valuable benchmarks for interpreting EPSI scores in the assessment and treatment of eating disorders among cisgender sexual minority individuals. Level of evidence: Level V: based on descriptive results.


  • Open Access

    Exposure to intimate partner violence and subsequent substance use among a nationwide sample of LGBTQIA+ people: results of The PRIDE Study

    by Nicholas Metheny, Nguyen Khai Tran, Gabriel John Dusing, Dalton Scott, Micah E Lubensky, Mitchell R Lunn, Juno Obedin-Maliver, Annesa Flentje

    Background: Individuals who are lesbian, gay, bisexual, transgender, queer or questioning, intersex, aromantic, asexual, or another sexual or gender minority (LGBTQIA+) are at greater risk of both intimate partner violence (IPV) and substance use compared to their cisgender, heterosexual counterparts. However, knowledge regarding the complex relationship between IPV and substance use in LGBTQIA+ communities is limited. Methods: This study used data from 2 years of The PRIDE (Population Research in Identity and Disparities for Equality) Study, a nationwide, community-based sample of LGBTQIA+ adults in the United States. Past-year IPV in 2021 was measured using the Extended-Hurt, Insulted, Threaten, Scream scale. Substances used in 2022 were measured via the NIDA-Modified Alcohol, Smoking, and Substance Involvement Screening Test (NM ASSIST). Linear and modified Poisson regression models explored temporal relationships between past-year IPV and prospective substance use. Results: Participants (n = 3745) were relatively young (median= 34 years, interquartile range: 27.6-48.5) and represented diverse LGBTQIA+ subcommunities. Approximately one-quarter (23.7%) were cisgender women and 17% were cisgender men. Half (49.2%) were gender minority people. Overall, one-quarter (24.6%) reported exposure to IPV in 2021. In adjusted models, past-year IPV was associated with prospective substance use (risk ratio [RR]: 1.11; 95% CI, 1.03-1.19). Additionally, more frequent IPV was associated with a higher prospective NM ASSIST score for cannabis (B: 0.22; 95% CI, 0.08-0.36), stimulants (B: 0.20; 95% CI, 0.06-0.35), hallucinogens (B: 0.07; 95% CI, 0.02-0.12), and narcotics (B: 0.12; 95% CI, 0.03-0.20). Conclusions: Exposure to IPV in 2021 was linked to greater substance use in 2022. Findings underscore the role of IPV in substance use among LGBTQIA+ people. Furthermore, they point to the need for increased IPV screening and referral among LGBTQIA+ people, as well as the potential efficacy of trauma-informed substance use interventions that address IPV.


  • Substance Use Over Time Among Sexual and Gender Minority People: Differences at the Intersection of Sex and Gender

    by Annesa Flentje, Gowri Sunder, Alexis Ceja, Nadra E. Lisha, Torsten B. Neilands, Bradley E. Aouizerat, Micah E. Lubensky, Matthew R. Capriotti, Zubin Dastur, Mitchell R. Lunn, et al.

    Purpose: Sexual and gender minority (SGM) people are at greater risk for substance use than heterosexual and cisgender people, but most prior work is limited by cross-sectional analyses or the examination of single substance use. This study examined substance use over time among SGM people to identify patterns of polysubstance use at the intersection of sex and gender. Methods: Data were collected annually over 4 years from SGM respondents (n = 11,822) in The Population Research in Identity and Disparities for Equality (PRIDE) Study. Differences in substance use patterns (any prior 30-day use of 15 substances) by gender subgroup were examined with latent class analysis, and multinomial regression models tested relationships between gender subgroup and substance use. Results: Eight classes of substance use were observed. The three most common patterns were low substance use (49%), heavy episodic alcohol use (≥5 alcoholic drinks on one occasion) with some cannabis and tobacco use (14%), and cannabis use with some tobacco and declining heavy episodic alcohol use (13%). Differences observed included lower odds of patterns defined by heavy episodic alcohol use with some cannabis and tobacco use in all gender subgroups relative to cisgender men and persons with low substance use (odds ratios [ORs] 0.26–0.60). Gender expansive people assigned female at birth, gender expansive people assigned male at birth, and transgender men had greater odds of reporting cannabis use with small percentages of heavy episodic alcohol and tobacco use (ORs: 1.41–1.60). Conclusion: This study suggests that there are unique patterns of polysubstance use over time among gender subgroups of SGM people.